PROOF Trial: Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangio
- This topic has 0 replies, 1 voice, and was last updated 4 years, 10 months ago by .
Viewing 1 post (of 1 total)
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.